Prostate Cancer Breakthrough
Men in England with low- and intermediate-risk prostate cancer will now have access to a revolutionary targeted radiotherapy, known as SABR, which reduces treatment sessions from 20 to just five 🌟. This form of radiotherapy will target the disease more effectively than standard radiotherapy and help reduce side-effects 🏥. What does this new development mean for the future of cancer treatment and patient care?
Read More











